Publication

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma

Journal Paper/Review - Jan 9, 2018

Units
PubMed
Doi

Citation
Hottinger A, Bodmer A, Weber D, Schaller K, Mach N, Hundsberger T, Vargas M, Dunkel N, Squiban D, Espeli V, Ben Aissa A, Dietrich P. Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma. Br J Cancer 2018
Type
Journal Paper/Review (English)
Journal
Br J Cancer 2018
Publication Date
Jan 9, 2018
Issn Electronic
1532-1827
Brief description/objective

This corrects the article DOI: 10.1038/bjc.2014.209.